Avalo Therapeutics AVTX
NASDAQ AVTX
$14.95 -0.38 (-2.48%)
At close: Oct 1, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Interest Expenses (2014 - 2015)

Updated

Avalo Therapeutics (AVTX) posted Interest Expenses of $197,470 for Q3 2015, up 4.1% from $189,679 a year earlier.

Analysis

Avalo Therapeutics (AVTX) Interest Expenses (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Avalo Therapeutics 668.42 Mn 668.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 197,470.00
Sep 30, 2014 189,679.00
API Access

Avalo Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=AVTX&period=max&api_key=YOUR_API_KEY